文献速递其他结缔组织病

肌炎相关普通型间质性肺炎生存优于特发性肺纤维化

Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

本研究比较肌炎相关普通型间质性肺炎(MA-UIP)与特发性肺纤维化(IPF-UIP)患者的生存结局,发现IPF-UIP的累积生存和无事件生存均显著差于MA-UIP,风险比分别为2.9和5.0(P<0.001),提示尽管病理和影像表现相似,MA-UIP预后更优。

要点

  • IPF-UIP累积生存和无事件生存均显著差于MA-UIP。
  • 调整协变量后,IPF-UIP无事件生存仍显著更差(HR 6.4)。
  • 活检证实的MA-UIP亚组分析结果相似。

核心结论

  • MA-UIP患者较匹配的IPF队列显示出显著的生存优势,提示尽管病理和影像表现相似,MA-UIP预后优于IPF-UIP。

研究设计与样本

  • 研究利用结缔组织病和IPF登记库识别成人MA-UIP和IPF-UIP患者,MA-UIP需有肌炎或抗合成酶综合征且高分辨率CT和/或肺活检示UIP,IPF符合美国胸科学会标准并有UIP组织病理。

主要发现

  • IPF-UIP累积生存和无事件生存均显著差于MA-UIP,风险比分别为2.9(95%CI:1.5,5.6)和5.0(95%CI:2.8,8.7),P<0.001。
  • 控制间质性肺病诊断年龄、性别、种族和基线用力肺活量百分比后,IPF-UIP无事件生存仍显著更差,风险比6.4(95%CI:3.0,13.8)。
  • 两组最常见死因均为呼吸衰竭;25例活检证实的MA-UIP亚组分析显示相似结果。

临床怎么用

  • 对于表现为UIP的间质性肺病患者,应评估肌炎或抗合成酶综合征,以区分MA-UIP与IPF-UIP,因两者预后不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the survival outcomes between myositis-associated usual interstitial pneumonia (MA-UIP) and idiopathic pulmonary fibrosis (IPF-UIP). METHODS: Adult MA-UIP and IPF-UIP patients were identified using CTD and IPF registries. The MA-UIP cohort included myositis or anti-synthetase syndrome patients with interstitial lung disease while manifesting UIP on high-resolution CT chest and/or a lung biopsy revealing UIP histology. IPF subjects met American Thoracic Society criteria and similarly had UIP histopathology. Kaplan-Meier survival curves compared cumulative and pulmonary event-free survival (event = transplant or death) between (i) all MA-UIP and IPF-UIP subjects, (ii) MA-UIP with biopsy proven UIP (n = 25) vs IPF-UIP subjects matched for age, gender and baseline forced vital capacity (±10%). Cox proportional hazards ratios compared the survival controlling for co-variates. RESULTS: Eighty-one IPF-UIP and 43 MA-UIP subjects were identified. The median cumulative and event-free survival time in IPF vs MA-UIP was 5.25/1.8 years vs 16.2/10.8 years, respectively. Cumulative and event-free survival was significantly worse in IPF-UIP vs MA-UIP [hazards ratio of IPF-UIP was 2.9 (95% CI: 1.5, 5.6) and 5.0 (95% CI: 2.8, 8.7) (P < 0.001), respectively]. IPF-UIP event-free survival (but not cumulative) remained significantly worse than MA-UIP with a hazards ratio of 6.4 (95% CI: 3.0, 13.8) after controlling for age at interstitial lung disease diagnosis, gender, ethnicity and baseline forced vital capacity%. Respiratory failure was the most common cause of death in both groups. A sub-analysis of 25 biopsy-proven MA-UIP subjects showed similar results. CONCLUSION: MA-UIP patients demonstrated a significant survival advantage over a matched IPF cohort, suggesting that despite similar histological and radiographic findings at presentation, the prognosis of MA-UIP is superior to that of IPF-UIP.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Aggarwal R, McBurney C, Schneider F, et al. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis. Rheumatology (Oxford). 2017. PMID: 28082622. doi:10.1093/rheumatology/kew426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。